期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

拉米夫定对慢性乙型肝炎临床治疗进展

Treatment progress of chronic hepatitis B with lamivudine
暂未订购
导出
作者 蒋绍香
机构地区 广西壮族自治区柳州市柳钢医院
出处 《华北煤炭医学院学报》 2002年第1期38-39,共2页 Journal of North China Coal Medical College
关键词 乙型肝炎 拉米夫定 治疗 进展 CHB 疗效 药物不良反应
分类号 R978.7 [医药卫生—药品] R512.62 [医药卫生—内科学]
  • 相关文献

参考文献16

  • 1Colledge D,Locarrini S,Shaw T,et al. Synergistic inhibition of hapadnavirai replication by lamivudine in combination with penciclovir in vitro. Hepatology, 1997,26(2) :216～225.
  • 2Lai CL,Ching Ck,Tung A KM,et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology,1997,25(1):241～244.
  • 3Nevens F, Main J, Honkoop P, et al. Lamivudine therapy for chronic hepatitis B: a six- month randomized dose - ranging study. Gastroenterology, 1997,113 (4) : 1258～ 1263.
  • 4姚光弼,王宝恩,崔振宇,姚集鲁,曾民德.拉米夫定治疗慢性乙型肝炎的多中心、随机双盲、安慰剂对照研究[J].中国新药与临床杂志,1999,18(3):131-135. 被引量：61
  • 5范桂玲,杜以真,秦来英.拉米夫定治疗慢性乙型肝炎128例疗效观察[J].临床荟萃,2000,15(4):160-161. 被引量：6
  • 6Lai CL,Chien RN,Leng MN,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia hepatitis lamivudine Study group. N Engl J Med,1998,39(2) :61～68.
  • 7Liaw YF,Lai CL,Leung NWY,et al. Two-year Lamivudine therapy in chonic hepatits B infection results of a placebo controlled multicentre study in Asia. Gastrienterology. 1998, 114 (4pt2): A1289.
  • 8Markowitz JS, Martin P, Conrad AJ,et al. Prophylaxis against hepatitis Brecurrence following Liver transplatation using combination Lamivudine and hepatitis B immune globulin. Hepatology, 1998,28(2): 585～589.
  • 9Van Thiel DH,Friedlander,Kania RJ,et al. Lamivudine treatment of advanced and decompensated liver disease due to hepatits B. Hepatogastroenterology, 1997,44(15) : 808～812.
  • 10Chan TM, Wu PC, Li FK, et al. Treatment of fihrosing cholestatic hepatits with lamivudine. Gastroenterology, 1998,115(1) : 177～181.

二级参考文献9

  • 1Lai C L，Hepatology，1997年，25卷，241页
  • 2Lai C L，J Hepatol，1997年，26卷，Suppl1期，79页
  • 3Dienstag JL,Robert P,Perrillo K,et al.A reliminary trail of lamivudine for heptitis B infection[].The New England Journal of Medicine.1995
  • 4Ono-Nita SK,Kato N,Shirator Y,et al.YMDD motif in heptitis Bvirus DNA polymerase influences on replication and lamivudine resistance: a study by in vitro full-length viral DNA transfection[].Hepatology.1999
  • 5Lai CL,Ching CK,Tung AKM,et al.Lamivudine is effective in suppressing heptitis B virus DNA in chinese heptitis Bsurface antigen carries: A placebo-controlled trial[].Hepatology.1997
  • 6Tyrrel DLJ,Fischer K,Sayani K,et al.Treatment of chimpanzees and ducks with lamivudine 2′- 3′- dideoxy- 3′- thiacytidine results in a repid suppression of hepadnaviral DNA in sera.Clin Invest Med, 1993,16(suppl) Abs[].No.
  • 7Doong SL,Tsai CH,Schinazi RF,et al.inhibition of the replication of hepatitis B virus in vitro by 2′, 3′- dideoxy - 3′- thiacytidine and related analogues[].Proceedings of the National Academy of Sciences of the United States of America.1991
  • 8Lai CL,Chien RN,Leung NWY,et al.One- year tyial of lamivudine for chronic heptitis B[].The New England Journal of Medicine.1998
  • 9姚光弼.抗乙型肝炎病毒新药拉米夫定[J].中国新药与临床杂志,1998,17(6):381-384. 被引量：40

共引文献65

华北煤炭医学院学报
2002年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部